Disposition of 7432-S in rats (I)

3Citations
Citations of this article
N/AReaders
Mendeley users who have this article in their library.
Get full text

Abstract

The absorption, excretion and metabolism of 7432-S were studied in male and female rats using 14C-labeled compound. 14C-7432-S, dissolved in phosphate buffer (10 mg/ml), was administered orally or intravenously to rats at 20 mg/kg or 5 mg/kg, respectively. When the drug was given orally, the plasma level of radioactivity reached maximum (9.18μg equivalent/ml) 30 min after the administration, then declined rapidly. Most of the plasma radioactivity was present as unchanged 7432-S and concentrations of 7432-S-trans were extremely low. Pharmacokinetic parameters of 7432-S after oral administration were as follows: Tmax was 24 min, Cmax was 7.44μg/ml and t1/2 was 52 min. The t1/2 after intravenous administration was 17.3 min. 7432-S was not absorbed from the stomach, caecum and colon, but from the small intestine. The rate of absorption in rats was estimated to be 50% of the dose from the sum of urinary and biliary excretions. After oral administration, 47% of the dose was excreted in the urine and 46% in the 4eces within 24 h. Unchanged 7432-S accounted for most of the urinary radioactivity and metabolites only for a small percentage. Biliary excretion of radioactivity in bile-duct cannulated rats was 8% of the dose after oral adminstration and 12% after intravenous administration within 24 h. Most of the radioactivity after oral administration was due to 7423-S, with 1.2% of B-1. © 1989, Japanese Society of Chemotherapy. All rights reserved.

Cite

CITATION STYLE

APA

Mizojiri, K., Takashima, A., Yukawa, T., & Akano, M. (1989). Disposition of 7432-S in rats (I). CHEMOTHERAPY, 37, 774–782. https://doi.org/10.11250/chemotherapy1953.37.Supplement1_774

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free